Abstract:Cell death in neurodegenerative diseases such as Alzheimer's disease (AD), and others is accompanied by reactivation of the neuronal cell cycle in members of populations at risk for death in the disease. The consistent relationship between cell death and cell cycle in these conditions suggests strongly that cell cycle regulation is crucial to the health and survival of a mature nerve cell. Despite the frequent correlation of cell cycle and cell death in the same neuronal populations, the mechanistic pathway linking the two remains undefined. primary neuron culture, western blotting, immunoprecipitation, immunostaining and live time imaging. One possible link is Cdk5. As the serine/threonine kinase, Cdk5 can hypophosphorlate Tau and induce the formation of Tau tangle. But, our recent data suggested that Cdk5 exerts a double protective function in neurons, first by suppressing the cell cycle in the nucleus and second by suppressing cell death in the cytoplasm. In AD patient's brain or AD mouse model, we found that the cycling neurons lost its nuclear Cdk5, and the negative correlation between Cdk5 with DNA damage marker 53BP1. We further investigated that Cdk5 nuclear localization relies on its binding to the cyclin dependent kinase inhibitor, p27. When a neuron is subjected to stress, such as exposure to β-amyloid, the Cdk5-p27 interaction is lost, reducing Cdk5 levels in the nucleus, and depriving the neuron of a major cell cycle suppression mechanism. Caspase-3 is activated within hours, but death is not immediate; elevated levels of cytoplasmic Cdk5 appear to retard neuronal death by a mechanism that may involve Bcl2 phosphorylation. These data suggest a model in which Cdk5 exerts a double protective function in neurons: chronically suppressing the cell cycle when located in the nucleus and transiently delaying cell death in the cytoplasm.

Cdk5 Levels Oscillate during the Neuronal Cell Cycle: Cdh1 UBIQUITINATION TRIGGERS PROTEOSOME-DEPENDENT DEGRADATION DURING S-PHASE

Nucleocytoplasmic Cdk5 Is Involved In Neuronal Cell Cycle And Death In Post-Mitotic Neurons

Cdk5 and the non-catalytic arrest of the neuronal cell cycle.

Cyclin Dependent Kinase 5 and Its Interacting Proteins in Cell Death Induced in Vivo by Cyclophosphamide in Developing Mouse Embryos

Nuclear Localization Of Cdk5 Is A Key Determinant In The Postmitotic State Of Neurons

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons

P1‐285: Nucleocytoplasmic Cdk5 Links Cell Cycle and Cell Death in Post‐mitotic Neurons in Alzheimer's Disease

Cdk5 Suppresses The Neuronal Cell Cycle By Disrupting The E2f1-Dp1 Complex

Cyclin-Dependent Kinase 5--A Neuronal Killer?

Cdk5 May Be an Atypical Kinase, but Not in the Way You Think

When Good Cdk5 Turns Bad

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

The roles of Cdk5-mediated subcellular localization of FOXO1 in neuronal death.

CDK5-cyclin B1 regulates mitotic fidelity

Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders

Apc/C-Cdh1 Targets Brain-Specific Kinase 2 (Brsk2) For Degradation Via The Ubiquitin-Proteasome Pathway

The Role of Cdk5 in Neurological Disorders

The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors

Neuroprotective Mechanisms Mediated by CDK5 Inhibition.

The Role of Cdk5 in Alzheimer’s Disease